Skip to main content
Home
Main navigation
  • Contents
    • Reactions
    • Expert voices
    • What we know
    • Resource library
    • Briefings
    • Training
    • SMC Studies
  • Journalists
  • Scientists
  • Press offices
  • About SMC ES
    • About SMC ES
    • The 5Ws +1
    • Statute
    • Advisory Committee
    • Working Method
    • Governance
    • Team
    • FAQ
  • Global network
User account menu - Secondary
  • ES
  • EN

Breadcrumb

  1. Home
Autor/es reacciones

Pablo Martínez-Lage Álvarez

 Neurologist, scientific director of the CITA-Alzheimer's Foundation
 

CITA-Alzheimer's Foundation
EMA revises earlier decision and decides to approve lecanemab for Alzheimer's disease
EN
Home
Science Media Centre Spain
 
bluesky  
 
Sobre SMC
  • What is the SMC Spain
  • Statute
  • Advisory Committee
  • CC Licence
  • FAQ
Contact the SMC

Do you have any questions or suggestions?

Write to us
Información
  • Legal Notice and Privacy Policy
  • Cookies Policy
  • Accesibilidad
© Science Media Centre 2021